Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in the Treatment of Allergic Conjunctivitis

• Status: Completed
• Trial end date: 2007-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the efficacy and safety of an anti-allergy drug with a contact lens compared to placebo in preventing ocular itching associated with allergic conjunctivitis

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Vistakon Pharmaceuticals
• Treatments: Anti-Allergic Agents; Ketotifen

Criteria

Inclusion Criteria:

• History of ocular allergies and a positive skin test reaction to cat hair, cat dander, grasses, ragweed, and/or trees withing the past 24 months

• Successful soft contact lens wearer who has frequently worn contact lenses for at least one month or more

Exclusion Criteria:

• Active ocular infection

• Clinically significant blepharitis

• Follicular conjunctivitis

• Pterygium

• Narrow angle glaucoma

• Dry eye dyndrome

• Ocular surgery within past 6 months

• Pregnancy or lactation